AMPH Amphastar Pharmaceuticals Earnings and EPS analysis

EPS in 2026 (TTM): $1.71

Last Report Period Date: Mar 31, 2026

Currently, AMPH's 12-month EPS stands at $1.71, according to the most recent financial reports. During 2025, AMPH reported a per-share earnings of $2.1, which shows a decline compared to the EPS of $3.29 recorded in 2024. AMPH recorded an EPS of $0.14 for the quarterly period ending on Mar 31, 2026.

In 2025, Amphastar Pharmaceuticals's earnings per share was $2.1, a decline of 36.2% from $3.29 in 2024. Over the quarter ending Mar 31, 2026, the earnings per share came in at $0.14, reflecting a 73.6% decline compared to the same quarter a year earlier. As of March 2026, the TTM EPS is $1.71. During 2024, the annual earnings per share was $3.29, representing an increase of 15.4% compared to 2023.

Amphastar Pharmaceuticals has recorded a decline in earnings per share of 73.6% in the past 12 months (YoY, quarterly). During the past three years, AMPH registered an average yearly EPS growth of 3.8%. Amphastar Pharmaceuticals had an average annual EPS growth of 133.9% in the last five years.